SCHEDULE 13G//SEC Filing
Aardvark Therapeutics, Inc. SCHEDULE 13G
Accession 0001415889-25-005246
CIK 0001834150other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:16 PM ET
Size
19.5 KB
Accession
0001415889-25-005246
Issuer
Decheng Capital Global Life Sciences Fund IV, L.P.
CIK 0001834150
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001834150
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:16 PM ET
- Size
- 19.5 KB